Le Lézard
Classified in: Health, Science and technology, Business
Subject: SVY

Canadian Employers Will Face a $5.6 Billion Price Tag for Specialty Drugs Within the Next Five Years


Innovative benefit management solutions required to maximize drug spending ROI

MISSISSAUGA, ON, May 10, 2016 /CNW/ - Express Scripts Canada, one of the country's leading providers of health benefits management services, today announced the results of its annual Drug Trend Report.

According to the report, which draws on analysis of prescription drug claims from millions of Canadians, high-cost specialty medications threaten the ability of employers to continue to offer a comprehensive prescription drug benefit to their employees.

Spending by Canadian employers on specialty drugs ? those used to treat chronic, complex conditions such as cancer and hepatitis C ? is expected to nearly double to $5.6 billion for private plans by 2020. Adding to concerns about newly approved treatments costing hundreds of thousands of dollars per patient are the 7,000 drugs currently in the development pipeline, most of which are specialty medications. At the same time, the number of patients requiring these treatments is rapidly increasing.

"From an economic and employee satisfaction perspective, the pharmacy benefit is highly valued by employers," says Michael Biskey, President of Express Scripts Canada. "It provides access to treatments on which many Canadians rely. However, unless plan sponsors take action now, it will quickly become unaffordable, making it necessary to transfer the burden of cost and financial risk to employees. If that happens, there is likely to be severe consequences for the health and financial wellbeing of Canadians."

Biskey stresses that Express Scripts Canada has applied clinical expertise, behavioural science and experience with millions of private plan members ? as well as advanced data analytics ? to develop solutions proven to balance costs and encourage healthier outcomes for employees. "Our active plan management and pharmacy solutions support employees and their families in achieving better health and reducing out-of-pocket costs while minimizing plan spending and contributing to better drug benefit ROI for employers. More optimized solutions and more educated choices mean less waste, which in turn means more funding for higher-cost specialty drugs when those potentially life-saving treatments are required by employees and their dependents."

Additional key findings from the study include:

About Express Scripts Canada

From its corporate headquarters just outside Toronto, Express Scripts Canada transforms the way organizations and employees think about and participate in their drug benefit plan. Express Scripts Canada provides pharmacy services to thousands of Canadian patients. Through its proprietary consumer intelligence, clinical expertise, and patients-first approach, Express Scripts Canada promotes better health decisions for plan members, while managing and reducing drug benefit costs for plan sponsors. Express Scripts Canada is indirectly owned by Express Scripts Holding Company.

SOURCE ESI Canada


These press releases may also interest you

at 18:07
Remote Patient Monitoring specialist, Advanced Remote Monitoring LLC (AARM) and sister company, Advanced Wearables Inc. (AWI) announce 360-degree solution for monitoring and isolating potential COVID-19 cases in partnership with IoT and smart...

at 18:05
The Ontario Catholic School Trustees' Association (OCSTA) announced today the ratification of central terms for a new three-year collective agreement with the Ontario English Catholic Teachers' Association (OECTA). "The unprecedented situation in our...

at 18:05
The board of directors of Entergy Corporation has approved a quarterly dividend payment of $0.93 per share on the company's common stock. The dividend is payable June 1, 2020, to shareholders of record as of May 7, 2020....

at 18:02
Lightspeed POS Inc. ("Lightspeed" or the "Company") , a leading cloud-based commerce platform, today provided an update on its business operations and announced the date for its fourth fiscal quarter and full year 2020 financial results conference...

at 17:55
CEMATRIX Corporation (the "Company" or "CEMATRIX") a North American leading manufacturer and supplier of technologically advanced cellular concrete products has appointed Gravitas Securities Inc. and Clarus Securities Inc. as co-lead agents to sell,...

at 17:50
HIVE Blockchain Technologies Ltd. (the "Company" or "HIVE") is pleased to announce that it has completed its previously announced acquisition (the "Acquisition") of a dedicated cryptocurrency mining operation with access to 30 megawatts ("MW") of...



News published on 10 may 2016 at 08:16 and distributed by: